HeartSciences(NASDAQ) HSCSW

Market CapN/A

Since IPO (2022)-100%

5 YearN/A

1 Year-33%

1 Month+5%

$0.04

-19.72%

-0.01Today

HeartSciences last closing stock price
Metric	Price	Date
Last close	USD 0.04	2026-08-31

HeartSciences stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-4.05%	USD 0.04	2026-08-24
1 month	+4.68%	USD 0.04	2026-07-31
3 month	-20.51%	USD 0.05	2026-06-02
Year to date	-42.59%	USD 0.07	2025-12-31
1 year	-32.95%	USD 0.06	2025-08-29
3 year	-99.42%	USD 7.00	2023-09-01
Since inception	-99.89%	USD 35.08	2022-06-15

HeartSciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$4.32K

Net Income (TTM)

-$9.14M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.92 (Low)

Dividend

$0.00

Beta (Volatility)

-0.92 (Low)

Price

$0.04

Volume

Open

$0.06

Price

$0.04

Volume

Open

$0.06

Previous Close

$0.04

Daily Range

$0.04 - $0.06

52-Week Range

$0.03 - $0.15

Estimated Earnings Date

Sep 10, 2026

Dividend

$0.00

Beta (Volatility)

-0.92 (Low)

Price

$0.04

Volume

Open

$0.06

Previous Close

$0.04

Daily Range

$0.04 - $0.06

52-Week Range

$0.03 - $0.15

Estimated Earnings Date

Sep 10, 2026

HSCSW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HeartSciences

HeartSciences Inc. is a medical technology company focused on developing innovative diagnostic instruments for cardiovascular health. The flagship product, MyoVista wavECG, is a sophisticated 12-lead resting electrocardiograph that provides critical insights into cardiac dysfunction.

Products and Services

MyoVista wavECG for advanced cardiac diagnostics
Standard 12-lead resting ECG capabilities
Solutions for clinics, hospitals, and urgent care centers

Growth Outlook

Significant market potential in cardiovascular diagnostics
Increasing adoption of MyoVista in diverse medical settings
Focus on expanding product offerings and technological advancements

Financial Highlights

Recent quarterly revenue of $0, indicating early-stage growth
Trailing twelve months (TTM) net income of -$8.5 million
Cash and short-term investments totaling $1.66 billion

HeartSciences Inc. operates in a critical sector, addressing the growing need for effective cardiovascular diagnostics. The MyoVista wavECG is positioned to enhance patient care through its advanced diagnostic capabilities. Despite recent financial challenges, the company maintains a strong cash position, which may support future growth initiatives. The focus on expanding its product line and increasing market penetration could provide significant opportunities for investors interested in the healthcare technology sector.

AI Generated • Aug 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

Southlake, TX 76092, US

HSCSW Financials

Key Financial Metrics (TTM)

Gross Margin

-2982.10%

Operating Margin

-194787.38%

Net Income Margin

-211666.47%

Return on Equity

-358.44%

Return on Capital

-0.20%

Return on Assets

-173.71%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

Avg. Volume

2.05K

Financials (TTM)

Gross Profit

-$128.80K

Operating Income

-$8.41M

EBITDA

-$8.41M

Operating Cash Flow

-$7.43M

Capital Expenditure

-$44.45K

Free Cash Flow

-$7.47M

Cash & ST Invst.

$1.66B

Total Debt

$3.94M

HeartSciences Performance Analysis

HeartSciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2025-07-31	-56.3%
Q2	2025-10-31	27.3%
Q4	2025-12-31	N/A
Q3	2026-01-31	-100.0%

HeartSciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2025-07-31	16.0%
Q2	2025-10-31	46.2%
Q4	2025-12-31	-36.5%
Q3	2026-01-31	25.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$33.24K

-15.4%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$1.99M

+5.2%

EBITDA

-$1.90M

-0.3%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

$1.66B

+150780.3%

Total Debt

$3.94M

+31.9%

Accounts Receivable

$0.00

-100.0%

Inventory

$655.63M

+100724.6%

Long Term Debt

$175.50K

-44.2%

Short Term Debt

$3.76M

+40.8%

Return on Assets

-1.74%

N/A

Return on Invested Capital

-20.95%

N/A

Free Cash Flow

-$1.49M

+6.8%

Operating Cash Flow

-$1.46M

+8.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BBLGBone Biologics Corporation

BBLGBone Biologics Corporation$0.58-6.18%

VEROVenus Concept Inc.

VEROVenus Concept Inc.$0.31+2.64%

NAOVNanoVibronix, Inc.

NAOVNanoVibronix, Inc.$1.90+1.06%

SHPHShuttle Pharmaceuticals Holdings, Inc.

SHPHShuttle Pharmaceuticals Holdings, Inc.$3.36-5.11%

DHAIDIH Holding US, Inc.

DHAIDIH Holding US, Inc.$0.00+0.00%

MOVECorvex, Inc.

MOVECorvex, Inc.$10.95-4.70%

BJDXBluejay Diagnostics, Inc.

BJDXBluejay Diagnostics, Inc.$0.87-3.33%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About HSCSW

What is the current price of HeartSciences?

HeartSciences is trading at $0.04 per share.

What is the 52-week range for HeartSciences?

Over the past 52 weeks, HeartSciences has traded between $0.03 and $0.15.

How much debt does HeartSciences have?

HeartSciences total debt is unavailable.

How much cash does HeartSciences have on hand?

HeartSciences does not have cash on hand data available.

What is HeartSciences’s dividend yield?

HeartSciences does not currently have a dividend yield.

HeartSciences(NASDAQ) HSCSW

HeartSciences Financials at a Glance

HSCSW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About HeartSciences

HSCSW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

HeartSciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HSCSW

What is the current price of HeartSciences?

What is the 52-week range for HeartSciences?

How much debt does HeartSciences have?

How much cash does HeartSciences have on hand?

What is HeartSciences’s dividend yield?

Premium Investing Services